Administered through weekly subcutaneous injections , Wegovy has demonstrated remarkable efficacy in clinical trials, helping patients achieve significant weight reduction while offering additional medical benefits
Retatrutide Side Effects Clinical trials show side effects common among GLP-1 receptor agonists
Avoid intense workouts, weightlifting, or high-impact cardio during your first 12 weeks on the medication, as your energy reserves are depleted
This is the latent stage
If you started blood pressure medication around the same time as tirzepatide, the fatigue may be partially or entirely from the antihypertensive, not the weight loss drug
Ideal candidates typically include: Adults with a BMI of 30 or higher (classified as obese) Adults with a BMI of 27 or higher who have at least one weight-related condition, such as type 2 diabetes, hypertension, high cholesterol, PCOS, or obstructive sleep apnea Individuals who have tried diet and exercise consistently but havent achieved meaningful weight loss Patients seeking a non-surgical, medication-based alternative to bariatric procedures People with insulin resistance, prediabetes, or blood sugar management challenges Semaglutide is not recommended for patients who are pregnant, breastfeeding, or planning to conceive, as well as those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
